SION — Sionna Therapeutics Share News
0.000.00%
- $162.76m
- -$48.27m
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial, Eli Lilly
U.S. STOCKS ON THE MOVE-Microsoft, Coastal Financial
Sionna hits record low after experimental drug misses mid-stage trial goal
Vertex Pharma rises after rival genetic disorder drug setback
U.S. STOCKS ON THE MOVE-SpaceX, AAON, Vertex Pharma
Vertex Pharma rises after rival genetic disorder drug setback
Sionna scraps genetic disorder drug program after trial setback; shares tank
U.S. STOCKS ON THE MOVE-Apple, Barrick Mining, AbCellera Biologics
Sionna falls after experimental drug misses mid-stage trial goal
Sionna Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Sionna Therapeutics Q2 net loss widens
Sionna Therapeutics Q1 net loss widens, misses estimates
Brief: Sionna Therapeutics Inc Maintains Strong Cash Position With About $310.3 Million In Cash And Cash Equivalents, Expected To Fund Operations Into 2028
Sionna Therapeutics reports smaller-than-expected Q4 net loss
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet
U.S. STOCKS ON THE MOVE-Constellation Energy, Williams-Sonoma
U.S. STOCKS ON THE MOVE-Lowe's, TJX Companies, Target
U.S. STOCKS ON THE MOVE-DoorDash, gold and silver miners
BTIG turns bullish on biotech sector, sees 2026 as 'banner year'